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Abstract
Background: We sought to explore whether the simplified Selvester QRS scoring system could
predict ST segment resolution in patients with first acute ST segment elevation myocardial
infarction who receive pharmacological reperfusion therapy.
Methods: We enrolled 60 consecutive patients admitted to the critical care unit with the
diagnosis of first acute ST segment elevation myocardial infarction presenting within 24 hours
from symptom onset, and eligible for reperfusion therapy. All patients received streptokinase in
the usual dose regimen. Patients underwent resting high-quality 12-lead electrocardiogram
recordings to calculate the modified QRS score and estimate the sum of ST segment elevation
before (STE1) and 90 minutes after (STE2) streptokinase. The difference between STE1 and
STE2 was then measured and accepted as the sum of ST segment resolution, expressed as SSTR.
Patients were classified into two groups: those with SSTR ≥ 50% of STE1 (the resolution
group) and those with SSTR < 50% (the non-resolution group).
Results: The mean QRS score was significantly lower in the resolution group compared to the
non-resolution group (2.88 ± 1.34 vs 5.93 ± 1.56, respectively, p < 0.001). There was
a highly significant negative correlation between QRS score and SSTR with a correlation
coefficient r = –0.76. Using a cut-off value of ≥ 4, the QRS score had a sensitivity of 93%,
specificity of 72%, positive and negative predictive values of 74% and 92% respectively, for
predicting SSTR < 50%.
Conclusions: The Selvester QRS score can reliably predict adequate ST segment resolution
in patients with first acute ST segment elevation myocardial infarction receiving fibrinolytic
therapy, with a high sensitivity and an acceptable specificity. (Cardiol J 2010; 17, 4: 367–373)
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Introduction
The immediate therapeutic goal of reperfusion
therapy is to restore full antegrade flow in the in-
farct-related epicardial coronary artery, as well as
to achieve adequate myocardial perfusion at tissue
level. Failure to improve tissue perfusion despite
successful restoration of epicardial coronary flow
(the so called ‘no-reflow phenomenon’) has been
associated with poor clinical outcome [1], and in-
dependently predicted six-months mortality [2]. It
is well established that early and complete resolu-
tion of ST-segment elevation is a powerful predic-
tor of infarct-related artery patency and preserved
myocardial perfusion at tissue level [3, 4].
Successful ST segment resolution as an elec-
trocardiographic sign of restored myocardial perfu-
sion  may vary according to how far the infarction
process has progressed. The presence of Q waves
at the time of presentation of first acute ST segment
elevation myocardial infarction (STEMI) reflects
a more advanced stage of the infarction process [5].
The Selvester QRS scoring system was initially
developed to estimate electrocardiographically the
size of myocardial infarction. It includes 54 criteria
that form the basis of a 32-point scoring system,
with each point equivalent to approximately 3% of
the left ventricle [6]. In fact, multiple versions of
the Selvester QRS score have been published which
help quantify myocardial scar in the presence of nor-
mal and abnormal ventricular conduction [7]. While
multiple versions of the Selvester QRS scoring sys-
tem have been reported, we chose to study the abi-
lity of the simplified QRS score [8], measured from
the admission (pre-thrombolytic) electrocardiogram
(ECG), to predict adequate resolution of ST seg-
ment elevation in patients with first acute STEMI
who receive pharmacological reperfusion therapy.
Methods
Patient selection
We enrolled 60 consecutive patients admitted
to our critical care unit between January 2007 and
January 2008, with the diagnosis of first acute
STEMI presenting within 24 hours from symptom
onset, eligible for reperfusion therapy (presenting
within 12 hours after symptom onset, or present-
ing thereafter with persistent symptoms). The dia-
gnosis of STEMI was based on 12-lead ECG show-
ing ST segment elevation ≥ 1 mm in at least two
contiguous leads plus one of the following: 1) pro-
longed chest discomfort typical of myocardial is-
chemia, 2) elevated cardiac biomarkers: creatine
kinase MB and/or troponin more than twice the
upper limit of normal lab reference. We excluded
patients with bundle branch block, paced rhythm,
left fascicle block, ECG signs of ventricular hyper-
trophy and those with cardiogenic shock. Before
inclusion, informed written consent was obtained
from each patient and the study protocol was re-
viewed and approved by our local institutional hu-
man research committee as it conforms to the eth-
ical guidelines of the 1975 Declaration of Helsinki,
as revised in 2002.
Definition of risk factors
The presence of hypertension was defined as
systolic blood pressure ≥ 140 mm Hg and/or dias-
tolic blood pressure ≥ 90 mm Hg, previously re-
corded by repeated non-invasive office measure-
ments, which lead to life-style modification or anti-
hypertensive drug therapy. The presence of
diabetes mellitus was defined as fasting plasma glu-
cose ≥ 126 mg/dL, and/or two hour post glucose
load ≥ 200 mg/dL, or specific anti-diabetic drug
therapy. Dyslipidemia was defined as LDL choles-
terol > 100 mg/dL, and/or serum triglycerides
> 150 mg/dL, and/or HDL cholesterol < 40 mg/dL
and < 50 mg/dL in women.
Methods
All included patients received fibrinolytic the-
rapy in the form of streptokinase by intravenous in-
fusion, at a dose of 1 500 000 U over 30–60 minutes.
Standard anti-ischemic medications were allowed
and remained unchanged during the study period.
All patients underwent resting high-quality 12-lead
ECG recordings, from which the following was es-
timated:
1. QRS score calculated according to the simpli-
fied form of the Selvester scoring system based
on 37 criteria capable of generating 29 points [8].
2. ST segment elevation, measured 20 ms after
the J point. The height (in mm) of ST segment
elevations was measured in leads I, aVL and
V1 through V6 for anterior infarctions, and in
leads II, III, aVF, V5 and V6 for inferior infarc-
tions. The sum of all measured ST segment
elevations was expressed as STE1.
Resting ECG was repeated for all patients
90 minutes following the initiation of fibrinolytic
therapy, from which the sum of ST segment eleva-
tions was measured again, as described before, and
expressed as STE2. The difference between STE1
and STE2 was then measured and accepted as the
sum of ST segment resolution, expressed as SSTR.
Patients were, subsequently, classified into two
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groups: those with SSTR ≥ 50% of STE1 (the reso-
lution group) and those with SSTR < 50% of STE1
(the non-resolution group).
Statistical analysis
All continuous variables were presented as
mean ± standard deviation, if they were normally
distributed. Differences in the normally distribut-
ed variables were assessed using the t-test and the
paired t-test for dependent variables. Categorical
variables were described with absolute and relative
(percentage) frequencies. Comparisons between
the two individual groups were performed using the
unpaired t-test (parametric) and Mann Whitney test
(non parametric) for continuous variables, and Pear-
son’s c2 test for categorical variables. Pearson’s cor-
relation coefficient test was performed to study the
correlation between the QRS score and the SSTR.
Finally, we generated receiver operating characte-
ristic (ROC) curves to identify the optimal cut-off va-
lue of QRS score that best predicts SSTR < 50% of
STE1. All tests were two-sided and a probability
value of p < 0.05 was considered statistically signif-
icant. Analyses were performed with SPSS version
12.0 statistical package (SPSS Inc., Chicago, IL, USA).
Results
A total of 60 consecutive patients with first
acute STEMI who received fibrinolytic therapy
were enrolled in the study. The baseline characteri-
stics of the overall cohort, as well as the two indi-
vidual study groups, are shown in Table 1. The
mean age was 54.7 ± 9.9 years, 53 (88.3%) being
males. The mean time from symptom onset to re-
perfusion was 3 ± 1.04 hours for the whole series.
As compared to the resolution group, patients in the
non-resolution group were older (57.4 ± 10.8 vs
52.3 ± 8.5 years respectively, p < 0.05), more likely
to be diabetic [17 (60.7%) vs 8 (25%) respectively,
p < 0.05], hypertensive [21 (75%) vs 11 (34.4%)
respectively, p < 0.05], but less likely to be dyslipi-
demic [13 (46.4%) vs 25 (78.1%) respectively, p < 0.05],
with a greater prevalence of dyspnea [13 (46.4%)
vs 2 (6.25%) respectively, p < 0.001], orthopnea
[8 (28.6%) vs 2 (6.25%) respectively, p < 0.05], and
basal cripitations [13 (46.4%) vs 2 (6.25%) respec-
tively, p < 0.001]. Similarly, patients in the non-
resolution group had a significantly longer time from
symptom onset to reperfusion (3.29 ± 1.15 vs 2.75 ±
± 0.88 h respectively, p < 0.05). Anterior rather
than inferior infarction was more prevalent in the non-
-resolution group than the resolution group (p < 0.05).
Table 2 shows the electrocardiographic data of
the overall cohort as well as the two study groups.
There was no significant difference between the
two groups concerning STE1 (p > 0.05). However,
STE2 was significantly lower in the resolution group
compared to the non-resolution group (3.47 ± 2.66
vs 8.71 ± 3.97 mm, respectively, p < 0.001). Ulti-
mately, the mean QRS score was significantly low-
er in the resolution group compared to the non-
Table 1. Baseline characteristics of the whole study cohort and the two study groups.
Whole cohort Resolution group Non-resolution P
(n = 60) (n = 32) group (n = 28)
Age (years) 54.7 ± 9.9 52.3 ± 8.5 57.4 ± 10.8 < 0.05
Males 53 (88.3) 30 (93.8) 23 (82.1) > 0.05
Smoking 31 (51.7) 20 (62.5) 11 (39.3) > 0.05
Diabetes 25 (41.7) 8 (25) 17 (60.7) < 0.05
Hypertension 32 (53.3) 11 (34.4) 21 (75) < 0.05
Dyslipidemia 38 (63.3) 25 (78.1) 13 (46.4) < 0.05
Family history of IHD 18 (30) 9 (28.1) 9 (32.1) > 0.05
Heart rate 84 ± 9 82 ± 7 86 ± 11 > 0.05
SBP [mm Hg] 118 ± 11 116 ± 8 120 ± 13 > 0.05
DBP [mm Hg] 77 ± 7 76 ± 6 78 ± 8 > 0.05
Anterior MI 36 (60) 14 (43.8) 22 (78.6) < 0.05
Dyspnea 15 (25) 2 (6.25) 13 (46.4) < 0.001
Orthopnea 10 (16.7) 2 (6.25) 8 (28.6) < 0.05
Basal cripitations 15 (25) 2 (6.25) 13 (46.4) < 0.001
3rd heart sound gallop 3 (5) 0 (0) 3 (10.7) > 0.05
Continuous variables are presented as mean ± standard deviation, while categorical variables are presented as numbers (percentage); SBP — systolic
blood pressure; DBP — diastolic blood pressure; IHD — ischemic heart disease; MI — myocardial infarction
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-resolution group (2.88 ± 1.34 vs 5.93 ± 1.56 re-
spectively, p < 0.001).
There was a highly significant negative corre-
lation between QRS score and SSTR with a corre-
lation coefficient r = –0.76 (Fig. 1). Receiver oper-
ating characteristic (ROC) curves identified a cut-
off value of ≥ 4 as the optimal cut-off value of QRS
score that best predicted SSTR < 50% of STE1.
Using this cut-off value, the QRS score had a sen-
sitivity of 93%, specificity of 72%, positive and neg-
ative predictive values of 74% and 92% respective-
ly, for predicting SSTR < 50% of STE1 (Fig. 2).
Discussion
The prognostic value of ST segment resolution
has been extensively studied in thrombolysis tri-
als, showing that patients with acute STEMI who
have incomplete ST segment resolution are more
prone to have persistent infarct-related artery oc-
clusion [9], larger infarct size [10], and a higher risk
of death and congestive heart failure [11]. On the
other hand, it was established that complete ST
segment resolution is a powerful predictor of in-
farct-related artery patency and preserved myocar-
dial tissue perfusion [3, 4]. In this regard, the pre-
sence of abnormal Q waves on admission in patients
with acute STEMI can predict slower and less com-
plete ST segment resolution, thus reflecting re-
duced myocardial perfusion even with patent in-
farct-related artery [12].
Previously, one study with Doppler guidewire
demonstrated that coronary flow velocity pattern
specific to substantial no-reflow was found at the
moment of reperfusion in some patients. These
patients had a larger number of Q waves before
reperfusion, as compared to their counterparts with
velocity pattern characteristic of microvascular
perfusion [13]. Moreover, a former study showed
that abnormal Q waves on admission were associ-
ated with higher peak creatine kinase values, and
higher prevalence of heart failure and mortality in
patients with anterior myocardial infarction [14].
Ideally, an early prognostic indicator in patients
with acute myocardial infarction should be simple,
rapid, non-invasive and easy to perform in all pa-
tients. An assessment by ECG would fulfill all of
these criteria [11]. It has been demonstrated that
the presence of Q waves at presentation in patients
Table 2. Electrocardiographic data of the overall cohort and the two study groups.
Whole cohort Resolution group Non-resolution P
(n = 60)  (n = 32)  group (n = 28)
QRS score 4.3 ± 2.1 2.9 ± 1.3 5.9 ± 1.6 < 0.001
STE1 11.2 ± 6.4 10.6 ± 7.5 11.9 ± 4.9 > 0.05
STE2 5.9 ± 4.2 3.5 ± 2.7 8.7 ± 3.9 < 0.001
All variables are presented as mean ± standard deviation; STE1 — the sum of ST segment elevations at baseline; STE2 — the sum of ST segment
elevations at 90 minutes
Figure 1. Linear regression curve showing a highly si-
gnificant negative correlation between QRS score and
SST segment resolution.
Figure 2. Receiver operating characteristic (ROC) curve
showing the optimal cut-off point of QRS score that
best predicts SST segment resolution < 50%.
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with first acute STEMI reflects a more advanced
stage of the infarction [5]. Although the Selvester
QRS scoring system has gone originally developed
to estimate ‘electrocardiographically’ the infarct
size in a well-established infarction, we sought to
employ it (in a simplified form) to quantify the QRS
complexes during an early stage of an ongoing in-
farction process. In this way, we hypothesized, we
could have a measure of ‘how advanced the infarc-
tion process was. We adopted the ‘< 50%’ ST seg-
ment resolution as a cut-off level to predict failed
reperfusion, since it was formerly recognized as
a marker of failed thrombolysis [15], unfavorable
prognosis, and was even regarded as a recruitment
criterion for rescue angioplasty [16].
Prior work used Q wave cut-offs from the
Selvester scoring system combined with analysis
of the T wave amplitude to formulate the ‘Ander-
son-Wilkins Acuteness Score’ aiming to explore the
acuteness of ischemia in cases of STEMI and hence
predict the potential benefit from reperfusion the-
rapy [17–21]. It may be that the ‘Anderson-Wilkins
Acuteness Score’ can be improved by incorporating
more criteria from the Selvester score. Therefore,
it would be valuable to see if the more complete QRS
score provides value over what is now just Q wave
measurements in the Anderson-Wilkins score (along
with T wave amplitude measurements).
The current study demonstrated that a ‘sim-
plified form’ of the Selvester QRS score can reli-
ably identify patients with acute STEMI who would
achieve successful ST segment resolution after
receiving fibrinolytic therapy. In these patients,
a cut-off value of ≥ 4 of the simplified QRS score
could best isolate those who would have inadequate
ST segment resolution after this therapy. Patients
presenting beyond the time window of benefit from
fibrinolytic therapy (more than 12 h after symptom
onset), sometimes have persistent symptoms. In
these patients, giving fibrinolytic therapy might still
have a probable, though doubtful, role. Thus, it
seems appealing to identify those who are more
likely to benefit from fibrinolysis in this patient cat-
egory. Evaluation of the width and amplitude of QRS
complexes in admission ECG recordings (and hence
calculation of the QRS score) would simply and
readily offer the chance for this stratification. In this
way, one would avoid giving fibrinolytic therapy
(with its notorious risk of bleeding) to patients who
are less likely to get its benefit, and restrict it only
to those who are more likely to improve.
Moreover, ‘silent’ acute myocardial infarction
can be incidentally discovered in ECG recordings
of patients presenting with symptoms other than
chest pain, especially diabetics and patients who
develop infarction under general anesthesia. In
these patients, it is often hard to delineate precise-
ly the time of onset of infarction, and consequently
it is not clear whether the patient still lies within
the time window of thrombolysis. Under this situa-
tion, estimation of the QRS score would reliably
offer the opportunity to recognize patients who are
more likely to benefit from fibrinolytic regimens.
Furthermore, even among patients presenting with-
in the time window of thrombolysis, some have an
unusually elevated risk of bleeding (for example,
elderly patients). In these patients, finding a high
QRS score (at or above the cut-off value of 4) would
be a compelling factor against giving a fibrinolytic
regimen.
Formerly, one study concluded that a high QRS
score is an independent predictor of incomplete
ST segment recovery and 30-day major cardiac events
in patients with STEMI treated with primary percu-
taneous coronary intervention [5]. Evidence sug-
gests that the extent of myocardial salvage when
reperfusion is achieved with percutaneous interven-
tion is less time-dependent than that for thrombo-
lysis. The mechanisms underlying this disparity are
as yet unclear. However, they may include resto-
ration of full antegrade flow in the infarct-related
artery with percutaneous intervention, and decreas-
ing efficacy of fibrinolytic agents as coronary throm-
bi mature with the passage of time [22]. Therefore,
evaluating ‘how far the infarction process has gone’
would seem more essential in the setting of reper-
fusion by fibrinolytic regimens than when it is in-
tended by means of primary intervention.
Anterior (rather than inferior) infarction was
more prevalent in the group with incomplete ST
segment resolution (the non-resolution group).
Concordantly, De Lemos et al. [16] demonstrated
that patients with anterior infarction develop signi-
ficantly less ST segment resolution than those with
inferior infarction despite only modest differences in
epicardial blood flow. This suggests that ST resolu-
tion correlates less with epicardial blood flow in pa-
tients with anterior versus inferior infarction. The
frequent (normal) presence of J point elevation in the
precordial leads might serve to reduce the extent of
ST segment resolution that would, otherwise, be
observed. Furthermore, anterior infarction is often
associated with a larger infarct size and greater tis-
sue injury than inferior infarction [16].
Unsurprisingly, symptoms of left ventricular
dysfunction were commoner in patients with incom-
plete ST segment resolution (the non-resolution
group). Similarly, Iwakura et al. [23] noted that pa-
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tients with no-reflow evidenced by myocardial con-
trast echocardiography, had a significantly higher
Killip class on hospital admission than  those with
no evidence of no-reflow. Insufficient myocardial
perfusion at tissue level would lead to loss of more
contractile units, something that would translate
into poorer contractile function and pump failure.
Limitations of the study
Our findings are based on a single center study
with a relatively small cohort size;  a fact that makes
it difficult to generalize our results to cover all pa-
tients with acute STEMI. Multicenter studies us-
ing the same protocol and examining a larger num-
ber of patients are needed before firm conclusions
can be adequately made. Furthermore, the perfor-
mance of an absolute QRS score partition value
might be modified by the proximity of the single
artery occlusion: an advanced small infarction due
to more distal occlusion with a small QRS score
might not be expected to ‘reperfuse’ as much as
a proximal obstruction that is associated with an early
and reversible injury, and that might have eventu-
ally a similar total score. Moreover, adequate fol-
low-up is needed to reveal whether the QRS score
can predict the occurrence of major adverse cardiac
events in the short and long term. Finally, consi-
dering the modest reperfusion rates of streptoki-
nase, it is not known exactly how many patients
eventually achieved successful reperfusion. Ade-
quate tissue reperfusion would be more precisely
evaluated by other techniques such as myocardial
contrast echocardiography. Comparing both the la-
ter-phase and pre-discharge QRS score findings in
these patients would add further value in demon-
strating the ‘ultimate’ infarct size in the group with
adequate, as well as inadequate, ST segment reso-
lution. This question remains open for future re-
search.
Conclusions
A ‘simplified form’ of the Selvester QRS score
can reliably predict the occurrence of adequate
ST segment resolution in patients with first acute
STEMI receiving fibrinolytic therapy. Using the
cut-off value of ≥ 4, the QRS score can predict in-
adequate ST segment resolution with a high sensi-
tivity and an acceptable specificity.
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